Shahla Masood, MD
Professor And Chair, Department Of Pathology And Laboratory Medicine; Program Director, Breast Pathology And Cytopathology Fellowships; Medical Director, UF Health Jacksonville Breast Center; Medical Director, UF Health Jacksonville Laboratories
Department:
Pathology – Jacksonville
Business Phone:
(904) 244-4387
Business Email:
shahla.masood@jax.ufl.edu
About Shahla Masood
Shahla Masood, M.D., is a University of Florida professor and chair of pathology, and is a board-certified pathologist and cytopathologist at UF Health Jacksonville. She serves as program director for the Breast Pathology Fellowship and the Cytopathology Fellowship programs. She is also medical director for the UF Health Breast Center and is director of research. She received her medical degree from Shiraz University in Shiraz, Iran. She completed an anatomic and clinical pathology residency, as well as a cytopathology fellowship, at Jacksonville Health Education Programs in Jacksonville, Florida. Dr. Masood has devoted her entire professional life to advancing breast health. Her clinical and research interests are rooted in breast pathology, cytopathology, early breast cancer detection, use of minimally invasive procedures to provide optimal samples for analysis, and prognostic and predictive factors in breast cancer. She launched an annual, international Multidisciplinary Symposium on Breast Health in 1995 focused on appropriateness of clinical cancer care and improving breast health literacy around the world, and has hosted the symposium in several international cities, including Rome, Paris, Cairo, Dammam (Saudi Arabia) and Tehran (Iran). Dr. Masood also serves as editor of The Breast Journal, the first comprehensive, multidisciplinary medical journal devoted exclusively to all facets of research, diagnosis and treatment of breast disease. Additionally, since 2000, Dr. Masood has hosted an annual public forum on breast health. The free event brings breast health education to some of Jacksonville’s most medically underserved communities.
Accomplishments
Emeritus Member, Board of Directors
2019
·
Florida Breast Cancer Foundation
America’s Top Doctors for Cancer
2013
·
Castle Connolly Medical Ltd.
Medical Adviser, Duval County Unit
2012
·
American Cancer Society
Chair, Scientific Committee
2010-2013
·
Florida Breast Cancer Foundation
Teaching Profile
Courses Taught
2013,2018
MDT7530 Elect Top/Pathology
2010-2013
MEL7936 Elect Top/Pathology
Board Certifications
-
CytopathologyAmerican Board of Pathology
-
Pathology – Anatomic and ClinicalAmerican Board of Pathology
Clinical Profile
Specialties
- Anatomic and Clinical Pathology
- Pathology
- Pathology, Immunology and Laboratory Medicine
Subspecialties
- Cytopathology
Areas of Interest
- Breast Biopsy – Open
- Breast Biopsy – Stereotactic
- Breast Biopsy – Ultrasound
- Breast Cancer
Research Profile
Areas of Interest
- Early breast cancer detection
- Minimally invasive breast biopsy
- Prognostic and predictive index for breast cancer
Publications
Academic Articles
2024
Malignant Phyllodes Tumor With Chondroblastic Osteosarcomatous Differentiation: A Case Report.
Cureus.
16(7)
[DOI] 10.7759/cureus.63915.
[PMID] 39105035.
2023
Complete Genome Sequence of Pseudomonas aeruginosa Phage UF_RH6, Isolated from Human Lung.
Microbiology resource announcements.
12(6)
[DOI] 10.1128/mra.00206-23.
[PMID] 37249420.
2023
Exploring New Frontiers in the Role of Breast Pathologists in Breast Cancer.
Advances in anatomic pathology.
30(6):359-360
[DOI] 10.1097/PAP.0000000000000417.
[PMID] 37746877.
2023
Is it Time to Retire the Term of Low-Grade Ductal Carcinoma in Situ and Replace it With Ductal Neoplasia?
Advances in anatomic pathology.
30(6):361-367
[DOI] 10.1097/PAP.0000000000000418.
[PMID] 37746902.
2022
Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer.
Cancers.
14(7)
[DOI] 10.3390/cancers14071846.
[PMID] 35406618.
2022
Intraindividual Reliability of Opportunistic Computed Tomography-Assessed Adiposity and Skeletal Muscle Among Breast Cancer Patients.
JNCI cancer spectrum.
6(6)
[DOI] 10.1093/jncics/pkac068.
[PMID] 36222575.
2022
Toward realization of remote controlled telecytopathology-a validation study from a large academic medical center from the southeast United States.
Journal of the American Society of Cytopathology.
11(5):320-327
[DOI] 10.1016/j.jasc.2022.04.003.
[PMID] 35589507.
2021
Changing the philosophy, direction, and the governance of The Breast Journal as it moves towards becoming an “Open Access” journal in 2022.
The breast journal.
27(1):5-6
[DOI] 10.1111/tbj.14145.
[PMID] 33368841.
2021
Farewell to The Breast Journal: A novel scientific publication led by a pathologist who moved beyond the microscope and faced the patients.
The breast journal.
27(12):849-850
[DOI] 10.1111/tbj.14304.
[PMID] 34897874.
2021
Prediction and assessment of response to neo-adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists.
The breast journal.
27(8):629-630
[DOI] 10.1111/tbj.14274.
[PMID] 34331376.
2021
The continued role of intraoperative assessment of the surgical margins in lumpectomy samples.
The breast journal.
27(11):795-796
[DOI] 10.1111/tbj.14298.
[PMID] 34761478.
2021
The significance of accurate diagnosis of encapsulated papillary carcinoma of the breast by core needle biopsy.
The breast journal.
27(3):207-208
[DOI] 10.1111/tbj.14220.
[PMID] 33723925.
2021
This is Not Only about the Biology: The Socioeconomic Disparities among African American Women with Breast Cancer Still Play a Significant Role.
The breast journal.
27(7):571-572
[DOI] 10.1111/tbj.14263.
[PMID] 34145683.
2021
Why proper characterization of breast cancer subtypes makes a difference in patient care.
The breast journal.
27(9):689-690
[DOI] 10.1111/tbj.14285.
[PMID] 34431163.
2021
Why women with an average risk for breast cancer undergo contralateral breast mastectomy? Does healthcare coverage matter?
The breast journal.
27(10):743-745
[DOI] 10.1111/tbj.14293.
[PMID] 34582066.
2020
Breast cancer risk assessment and management.
The breast journal.
26(8)
[DOI] 10.1111/tbj.14013.
[PMID] 32783316.
2020
Breast cancer treatment: A phased approach to implementation.
Cancer.
126 Suppl 10:2365-2378
[DOI] 10.1002/cncr.32910.
[PMID] 32348571.
2020
Breast pathology: The core of an integrated practice of personalized breast care.
The breast journal.
26(6):1121-1122
[DOI] 10.1111/tbj.13873.
[PMID] 32372475.
2020
Celebrating a “Quarter of Century” contributions of The Breast Journal.
The breast journal.
26(1)
[DOI] 10.1111/tbj.13727.
[PMID] 31957908.
2020
Is it ductal carcinoma in situ with microinvasion or “Ductogenesis”? The role of myoepithelial cell markers.
The breast journal.
26(6):1138-1147
[DOI] 10.1111/tbj.13897.
[PMID] 32447817.
2020
Is it time to address the continuous dilemma of breast cancer disparities among African Americans? A call to action.
The breast journal.
26(12):2339-2340
[DOI] 10.1111/tbj.14124.
[PMID] 33283942.
2020
The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview.
Cancer.
126 Suppl 10(Suppl 10):2339-2352
[DOI] 10.1002/cncr.32891.
[PMID] 32348573.
2020
The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
The breast journal.
26(1):27-34
[DOI] 10.1111/tbj.13728.
[PMID] 31876097.
2020
The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.
The breast journal.
26(8):1583-1588
[DOI] 10.1111/tbj.14012.
[PMID] 32845077.
2020
Ultrastructural Characteristics of Gallbladder Epithelial Inclusions Mimicking Cystoisospora.
American journal of clinical pathology.
153(1):88-93
[DOI] 10.1093/ajcp/aqz137.
[PMID] 31600399.
2019
Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
The breast journal.
25(4):575-577
[DOI] 10.1111/tbj.13292.
[PMID] 31280501.
2016
Breast cancer subtypes: morphologic and biologic characterization.
Women's health (London, England).
12(1):103-19
[DOI] 10.2217/whe.15.99.
[PMID] 26756229.
2016
DNA Methylation of the hTERT Gene in Breast Cancer Revisited: Diagnostic and Clinical Implications.
Laboratory medicine.
47(4):293-299
[PMID] 27708168.
2016
Moving toward appropriateness of breast cancer care: a balanced act to redefine the scope of standard of care.
Women's health (London, England).
12(2):163-6
[DOI] 10.2217/whe-2015-0002.
[PMID] 26901376.
2016
Neoadjuvant chemotherapy in breast cancers.
Women's health (London, England).
12(5):480-491
[PMID] 27885165.
2016
The potential of identification of a malignancy-associated biomarker in breast cancer diagnosis and research: hTERT gene DNA methylation.
Diagnostic cytopathology.
44(8):670-5
[DOI] 10.1002/dc.23505.
[PMID] 27229911.
2015
Comparative cost-effectiveness of fine needle aspiration biopsy versus image-guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of Affordable Care Act: a changing landscape.
Diagnostic cytopathology.
43(8):605-12
[DOI] 10.1002/dc.23270.
[PMID] 25722099.
2015
Cytologic features of metanephric adenoma of the kidney: case report and review of the literature.
Laboratory medicine.
46(2):153-8; quiz e30
[DOI] 10.1309/LMW2MHDM6EILGQH2.
[PMID] 25918196.
2015
Development of a novel approach for breast cancer prediction and early detection using minimally invasive procedures and molecular analysis: how cytomorphology became a breast cancer risk predictor.
The breast journal.
21(1):82-96
[DOI] 10.1111/tbj.12362.
[PMID] 25556774.
2015
Diagnostic value and accuracy of imprint cytology evaluation during image-guided core needle biopsies: Review of our experience at a large academic center.
Diagnostic cytopathology.
43(10):773-9
[DOI] 10.1002/dc.23300.
[PMID] 26119885.
2015
Htert Gene Expression and Dna Methylation in Breast Cancer Revisited By Realtime Rt-Pcr and Methylation Specific Pcr
Laboratory Investigation.
95(1):72A-73A
2015
Is digoxin a breast cancer risk factor?
Acute cardiac care.
17(2):29-31
[DOI] 10.3109/17482941.2015.1066823.
[PMID] 26458027.
2015
Minimizing Errors in Breast Pathology: A Call for Action.
The breast journal.
21(4):333-6
[DOI] 10.1111/tbj.12440.
[PMID] 26136182.
2014
Appropriateness of breast cancer care: a changing landscape focusing on proper utilization of resources and patients’ choices.
The breast journal.
20(1):1-2
[DOI] 10.1111/tbj.12224.
[PMID] 24438062.
2014
Htert Gene Dna Methylation Index and Breast Invasive Ductal Carcinoma
Laboratory Investigation.
94(1):66A-67A
2013
Building access to quality breast pathology diagnosis across the globe: a call for action.
The breast journal.
19(3):229-30
[DOI] 10.1111/tbj.12120.
[PMID] 23614362.
2013
Focusing on breast cancer overdiagnosis and overtreatment: the promise of molecular medicine.
The breast journal.
19(2):127-9
[DOI] 10.1111/tbj.12095.
[PMID] 23458217.
2013
Ultrasound guided fine needle aspiration biopsy: the new challenges and opportunities for cytopathologists.
Diagnostic cytopathology.
41(12):1017-8
[DOI] 10.1002/dc.23057.
[PMID] 24167040.
2012
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.
The breast journal.
18(4):303-11
[DOI] 10.1111/j.1524-4741.2012.01264.x.
[PMID] 22759093.
2012
Changing the term “breast tumor resembling the tall cell variant of papillary thyroid carcinoma” to “tall cell variant of papillary breast carcinoma”.
Advances in anatomic pathology.
19(2):108-10
[DOI] 10.1097/PAP.0b013e318249d090.
[PMID] 22313838.
2012
Characteristics of systemic diseases in the breast: clinical, imaging and pathologic features.
Women's health (London, England).
8(5):593-9
[DOI] 10.2217/whe.12.45.
[PMID] 22934732.
2012
Cytomorphology of male breast lesions: diagnostic pitfalls and clinical implications.
Diagnostic cytopathology.
40(2):179-84
[DOI] 10.1002/dc.21601.
[PMID] 22246937.
2012
Expanded role of cytopathology in breast cancer diagnosis, therapy and research: the impact of fine needle aspiration biopsy and imprint cytology.
The breast journal.
18(1):1-2
[DOI] 10.1111/j.1524-4741.2011.01199.x.
[PMID] 22226067.
2012
New insights from breast pathology: should we consider low grade DCIS NOT a cancer?
European journal of radiology.
81 Suppl 1:S93-4
[DOI] 10.1016/S0720-048X(12)70037-2.
[PMID] 23083619.
2012
Rapid assessment breast clinic: how to offer the same day diagnosis?
The breast journal.
18(2):101-2
[DOI] 10.1111/j.1524-4741.2012.01225.x.
[PMID] 22404049.
2012
Reproducibility of breast biopsy.
European journal of radiology.
81 Suppl 1:S95-6
[DOI] 10.1016/S0720-048X(12)70038-4.
[PMID] 23083620.
2012
The clinical significance of recognizing distinct morphologic features of systemic diseases on breast biopsies.
Advances in anatomic pathology.
19(4):217-9
[DOI] 10.1097/PAP.0b013e31825c6b58.
[PMID] 22692284.
2012
The value of fine needle aspiration biopsy in the diagnosis and prognostic assessment of palpable breast lesions.
Diagnostic cytopathology.
40(1):26-34
[DOI] 10.1002/dc.21497.
[PMID] 22180235.
2012
Why the term ‘low-grade ductal carcinoma in situ’ should be changed to ‘borderline breast disease’: diagnostic and clinical implications.
Women's health (London, England).
8(1):57-62
[DOI] 10.2217/whe.11.88.
[PMID] 22171775.
2011
Achieving excellence as a breast health educator at a global level: a new initiative of the World Society for Breast Health.
The breast journal.
17(3):221-2
[DOI] 10.1111/j.1524-4741.2011.01087.x.
[PMID] 21545432.
2011
Borderline breast lesions: diagnostic challenges and clinical implications.
Advances in anatomic pathology.
18(3):190-8
[DOI] 10.1097/PAP.0b013e31821698cc.
[PMID] 21490436.
2011
Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative.
Breast (Edinburgh, Scotland).
20 Suppl 2:S12-9
[DOI] 10.1016/j.breast.2011.02.015.
[PMID] 21388811.
2011
Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care.
Annals of clinical and laboratory science.
41(1):8-13
[PMID] 21325248.
2011
The use of fine-needle aspiration biopsy samples for the assessment of basal phenotype in triple negative breast cancer patients: a correlative study.
Diagnostic cytopathology.
39(1):1-7
[DOI] 10.1002/dc.21312.
[PMID] 20091704.
2010
Evidence-based contributions of cytopathology to breast cancer diagnosis and research: how to sustain training and education in breast cytopathology?
The breast journal.
16(5):457-9
[DOI] 10.1111/j.1524-4741.2010.00972.x.
[PMID] 21054643.
2010
How to restore public trust about breast cancer screening? An opportunity to reinforce the need for further advances in science and technology and access to care.
The breast journal.
16(1):1-3
[DOI] 10.1111/j.1524-4741.2009.00893.x.
[PMID] 20465597.
2010
Is it time to retire the term of “in situ carcinoma” and use the term of “borderline breast disease?”.
The breast journal.
16(6):571-2
[DOI] 10.1111/j.1524-4741.2010.01014.x.
[PMID] 21070432.
2010
Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall.
Pathology, research and practice.
206(8):544-9
[DOI] 10.1016/j.prp.2010.02.010.
[PMID] 20359832.
2010
Study and management of breast disease.
The breast journal.
16 Suppl 1
[DOI] 10.1111/j.1524-4741.2010.00991.x.
[PMID] 21050298.
2009
“Early View”: a new initiative of the Breast Journal.
The breast journal.
15(3):221-2
[DOI] 10.1111/j.1524-4741.2009.00734.x.
[PMID] 19645774.
2009
Breast cancer risk assessment and follow-up management: is there a magic marker to identify high risk individuals?
The breast journal.
15 Suppl 1
[DOI] 10.1111/j.1524-4741.2009.00856.x.
[PMID] 19775323.
2009
Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
Diagnostic cytopathology.
37(5):324-32
[DOI] 10.1002/dc.21006.
[PMID] 19191294.
2009
Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
Diagnostic cytopathology.
37(3):184-90
[DOI] 10.1002/dc.20982.
[PMID] 19170172.
2009
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Cancer prevention research (Philadelphia, Pa.).
2(3):265-73
[DOI] 10.1158/1940-6207.CAPR-08-0119.
[PMID] 19223577.
2009
Implementation of the suggested guidelines for breast cancer risk, genetics, and risk assessment: the critical need for educating practicing physicians.
The breast journal.
15(1):1-3
[DOI] 10.1111/j.1524-4741.2008.00684.x.
[PMID] 19141129.
2009
Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Pathology international.
59(6):405-9
[DOI] 10.1111/j.1440-1827.2009.02385.x.
[PMID] 19490472.
2009
Papillary thyroid carcinoma with metastasis to the frontal skull.
Diagnostic cytopathology.
37(7):522-6
[DOI] 10.1002/dc.21070.
[PMID] 19459156.
2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
The breast journal.
15(1):4-16
[DOI] 10.1111/j.1524-4741.2008.00665.x.
[PMID] 19141130.
2009
The challenge of apocrine proliferations of the breast: a morphologic approach.
Pathology, research and practice.
205(3):155-64
[DOI] 10.1016/j.prp.2008.11.010.
[PMID] 19147303.
2008
Breast pathology guideline implementation in low- and middle-income countries.
Cancer.
113(8 Suppl):2297-304
[DOI] 10.1002/cncr.23833.
[PMID] 18837021.
2008
Crossing the borders: an international breast health educational initiative–a collaboration between the American Cancer Society and the University of Florida, Jacksonville.
The breast journal.
14(1):1-2
[DOI] 10.1111/j.1524-4741.2007.00541.x.
[PMID] 18186861.
2008
Integration of professionalism and volunteerism in building the foundation of the “International Institute of Breast Pathology” a worldwide collaboration.
The breast journal.
14(2):125-7
[DOI] 10.1111/j.1524-4741.2008.00565.x.
[PMID] 18315689.
2008
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Breast cancer research and treatment.
112(2):327-33
[PMID] 18097749.
2008
Significance of patient education and counseling in improving breast healthcare.
Women's health (London, England).
4(6):551-5
[DOI] 10.2217/17455057.4.6.551.
[PMID] 19072456.
2008
Survivorship: a needed program for the continuity of care for breast cancer patients.
The breast journal.
14(6):515-6
[DOI] 10.1111/j.1524-4741.2008.00640.x.
[PMID] 19053999.
2008
The knowledge about risk for breast cancer: the patients’ right to know.
The breast journal.
14(3):219-20
[DOI] 10.1111/j.1524-4741.2008.00589.x.
[PMID] 18476881.
2008
The National Accreditation Program for Breast Centers: quality improvement through interdisciplinary evaluation and management.
Bulletin of the American College of Surgeons.
93(10):13-7
[PMID] 19469362.
2007
Coming together to conquer the fight against breast cancer in countries of limited resources: the challenges and the opportunities.
The breast journal.
13(3):223-5
[PMID] 17461894.
2007
Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies.
Diagnostic cytopathology.
35(10):653-5
[PMID] 17854082.
2007
The fine line between competency and quality performance in breast pathology: are we serving our patients right?
The breast journal.
13(5):441-2
[PMID] 17760663.
2007
Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
Diagnostic cytopathology.
35(10):656-9
[PMID] 17854083.
2006
An invitation to join the World Society of Breast Health.
The breast journal.
12(5 Suppl 2)
[PMID] 16958989.
2006
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
The breast journal.
12 Suppl 1:S3-15
[PMID] 16430397.
2006
Breast cancer in limited-resource countries: diagnosis and pathology.
The breast journal.
12 Suppl 1:S27-37
[PMID] 16430396.
2006
Breast cancer in resource-limited countries.
Women's health (London, England).
2(6):797-800
[DOI] 10.2217/17455057.2.6.797.
[PMID] 19803996.
2006
Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy: a case report and review of the literature.
Diagnostic cytopathology.
34(3):214-7
[PMID] 16548002.
2006
Raising the bar: a plea for standardization and quality improvement in the practice of breast pathology.
The breast journal.
12(5):409-12
[PMID] 16958956.
2005
Core needle biopsy versus fine needle aspiration biopsy: are there similar sampling and diagnostic issues?
Clinics in laboratory medicine.
25(4):679-88, vi
[PMID] 16308086.
2005
Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
Clinics in laboratory medicine.
25(4):827-43, viii
[PMID] 16308095.
2005
Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
Clinics in laboratory medicine.
25(4):713-31, vi
[PMID] 16308088.
2005
Nipple fluid cytology.
Clinics in laboratory medicine.
25(4):787-94, vii
[PMID] 16308092.
2005
Prognostic/predictive factors in breast cancer.
Clinics in laboratory medicine.
25(4):809-25, viii
[PMID] 16308094.
2004
Female genital schistosomiasis: case report and review of the literature.
Southern medical journal.
97(5):525-7
[PMID] 15180032.
2004
Influencing the change: building blocks for integration of care in breast centers.
The breast journal.
10(5):381-2
[PMID] 15327488.
2004
Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA.
Human pathology.
35(7):781-4
[PMID] 15257539.
2004
Report of the Working Groups on Breast MRI: report of the Breast Cancer Staging Group.
The breast journal.
10 Suppl 2:S3-8
[PMID] 15330873.
2004
Stromal infiltration as a predictor of tumor invasion in breast fine-needle aspiration biopsy.
Diagnostic cytopathology.
30(3):182-6
[PMID] 14986299.
2003
Core needle biopsy versus fine-needle aspiration biopsy: are there similar sampling and diagnostic issues?
The breast journal.
9(3):145-6
[PMID] 12752620.
2003
Diagnosis of breast cancer in countries with limited resources.
The breast journal.
9 Suppl 2:S60-6
[PMID] 12713498.
2003
Implementation of a minimally invasive breast biopsy program in countries with limited resources.
The breast journal.
9 Suppl 2:S81-5
[PMID] 12713501.
2003
Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Diagnostic cytopathology.
28(6):329-34
[PMID] 12768640.
2003
The expanding role of pathologists in the diagnosis and management of breast cancer: Worldwide Excellence in Breast Pathology Program.
The breast journal.
9 Suppl 2:S94-7
[PMID] 12713504.
2003
Why most women with breast cancer still undergo mastectomy.
The breast journal.
9(2):69-70
[PMID] 12603376.
2002
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research.
8(10):3105-17
[PMID] 12374678.
2002
A subset of breast invasive ductal carcinoma with distinctive cytomorphology, aggressive clinical behavior, and unique immunologic profiles.
Cancer.
96(5):294-300
[PMID] 12378597.
2002
Prognostic and predictive value of HER2/neu oncogene in breast cancer.
Microscopy research and technique.
59(2):102-8
[PMID] 12373720.
2002
The clinical significance of recognizing distinct morphologic and biologic features of hereditary breast cancer.
The breast journal.
8(2)
[PMID] 11896749.
2001
Expanding role of breast cytopathology as a risk predictor.
Advances in anatomic pathology.
8(5):255-63
[PMID] 11556533.
2000
Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study.
Annals of clinical and laboratory science.
30(3):259-65
[PMID] 10945565.
2000
Assessment of prognostic factors in breast fine-needle aspirates.
American journal of clinical pathology.
113(5 Suppl 1):S84-96
[PMID] 11993712.
2000
Breast Cancer Awareness and the Power of Advocacy.
The breast journal.
6(5)
[PMID] 11348381.
2000
Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
Annals of clinical and laboratory science.
30(1):33-40
[PMID] 10678581.
1999
Breast Health Education: Our Continuous Commitment.
The breast journal.
5(5)
[PMID] 11348303.
1999
Sampling of Nonpalpable Breast Lesions: A Plea for a Multidisciplinary Approach.
The breast journal.
5(2):79-80
[PMID] 11348264.
1999
The Missing Link: A “Pap Smear” For Early Breast Cancer Detection and Prevention.
The breast journal.
5(1):1-2
[PMID] 11348248.
1998
Automation in cytology: a survey conducted by the New Technology Task Force, Papanicolaou Society of Cytopathology.
Diagnostic cytopathology.
18(1):47-55
[PMID] 9451558.
1998
Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Annals of clinical and laboratory science.
28(6):315-23
[PMID] 9846198.
1998
Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
Annals of clinical and laboratory science.
28(3):138-43
[PMID] 9646853.
1998
Nuclear grooves in fine-needle aspiration biopsies of breast lesions: do they have any significance?
Diagnostic cytopathology.
18(5):333-7
[PMID] 9582567.
1998
Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. For enumeration of gene amplification in paraffin-embedded specimens: a multicenter clinical validation study.
Annals of clinical and laboratory science.
28(4):215-23
[PMID] 9715348.
1997
Fat embolism with the use of intraosseous infusion during cardiopulmonary resuscitation.
The American journal of the medical sciences.
314(2):73-9
[PMID] 9258208.
1997
The prognostic value of HER-2/neu oncogene in cervical cancer.
Annals of clinical and laboratory science.
27(6):396-401
[PMID] 9433536.
1997
Why women still die from cervical cancer.
The Journal of the Florida Medical Association.
84(6):379-83
[PMID] 9379163.
1996
Altered expression of alpha-smooth muscle isoactin in Hirschsprung’s disease.
Archives of pathology & laboratory medicine.
120(3):270-4
[PMID] 8629903.
1996
Breast health. Challenges and promises.
The Journal of the Florida Medical Association.
83(7):459-65
[PMID] 8824086.
1995
Application of immunostaining for muscle specific actin in detection of myoepithelial cells in breast fine-needle aspirates.
Diagnostic cytopathology.
13(1):71-4
[PMID] 7587880.
1995
Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Surgical oncology clinics of North America.
4(4):601-32
[PMID] 8535901.
1995
Prognostic factors in breast cancer: use of cytologic preparations.
Diagnostic cytopathology.
13(5):388-95
[PMID] 8834313.
1994
Prognostic and diagnostic implications of estrogen and progesterone receptor assays in cytology.
Diagnostic cytopathology.
10(3):263-7
[PMID] 8050334.
1994
Standardization of immunobioassays as surrogate endpoints.
Journal of cellular biochemistry. Supplement.
19:28-35
[PMID] 7823602.
1994
Unsuspected metastatic renal cell carcinoma diagnosed by fine needle aspiration biopsy. A report of four cases with immunocytochemical contributions.
Acta cytologica.
38(4):554-61
[PMID] 8042422.
1993
Cytology of malignant schwannoma metastatic to the lung. Report of a case with diagnosis by fine needle aspiration biopsy.
Acta cytologica.
37(3):409-12
[PMID] 8388612.
1993
Ductal carcinoma in situ of the breast.
Surgery, gynecology & obstetrics.
177(4):425-40
[PMID] 8211592.
1993
Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study.
Cancer.
72(2):511-8
[PMID] 8319181.
1992
Diagnosis of tuberculosis of bone and soft tissue by fine-needle aspiration biopsy.
Diagnostic cytopathology.
8(5):451-5
[PMID] 1396023.
1992
Estrogen and progesterone receptors in cytology: a comprehensive review.
Diagnostic cytopathology.
8(5):475-91
[PMID] 1396026.
1992
Expression of steroid hormone receptors in benign hepatic tumors. An immunocytochemical study.
Archives of pathology & laboratory medicine.
116(12):1355-9
[PMID] 1333749.
1992
Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas.
Cancer.
70(8):2109-14
[PMID] 1327487.
1992
Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Cancer detection and prevention.
16(4):225-35
[PMID] 1281040.
1992
Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions.
Diagnostic cytopathology.
8(2):161-6
[PMID] 1568413.
1991
Application of estrogen receptor immunocytochemical assay to aspirates from mammographically guided fine needle biopsy of nonpalpable breast lesions.
Southern medical journal.
84(7):857-61
[PMID] 1712514.
1991
Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates.
Diagnostic cytopathology.
7(6):581-90
[PMID] 1769286.
1991
Fine needle aspiration cytology of papillary endometrioid carcinoma of the prostate. The grooved nucleus as a cytologic marker.
Acta cytologica.
35(4):451-5
[PMID] 1718114.
1991
Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates.
American journal of clinical pathology.
95(1):35-40
[PMID] 1987750.
1991
Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization.
Southern medical journal.
84(2):235-6
[PMID] 1703667.
1991
Immunocytochemical analysis of progesterone receptors in breast cancer.
American journal of clinical pathology.
96(1):59-63
[PMID] 1712544.
1991
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.
The American journal of pathology.
139(2):245-50
[PMID] 1714241.
1990
Extragenital granuloma inguinale mimicking a soft-tissue neoplasm: a case report and review of the literature.
Human pathology.
21(5):559-61
[PMID] 1692564.
1990
Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
3(6):724-8
[PMID] 1702213.
1990
Potential value of hormone receptor assay in carcinoma in situ of breast.
American journal of clinical pathology.
94(5):533-7
[PMID] 2173395.
1990
Potential value of immunoperoxidase technique in assessment of genital herpes.
The Journal of the Florida Medical Association.
77(5):516-9
[PMID] 2112586.
1990
Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions.
Cancer.
66(7):1480-7
[PMID] 2169989.
1989
The potential value of mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions.
The American surgeon.
55(4):226-31
[PMID] 2705686.
1989
Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
Archives of pathology & laboratory medicine.
113(1):26-30
[PMID] 2462858.
1988
Fine needle aspiration cytology of chondroid syringoma. Report of a case.
Acta cytologica.
32(4):482-4
[PMID] 2456654.
1988
The potential value of imprint cytology in cytochemical localization of steroid hormone receptors in ovarian cancer.
Diagnostic cytopathology.
4(1):42-7
[PMID] 3288456.
1988
Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer.
Cancer detection and prevention.
12(1-6):283-90
[PMID] 3052833.
Grants
Dec 2023
ACTIVE
Standardizing Androgen Receptor Assessment and Exploring Targetable Alterations in Quadruple Negative Breast Cancer
Role: Principal Investigator
Funding: MAYO CLINIC
via NRG ONCOLOGY FOU
Jan 2019
– Jan 2024
MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (Flex Registry)
Role: Principal Investigator
Funding: AGENDIA
Mar 2016
– Aug 2019
Biobank for African American Prostate Cancer Research in Florida
Role: Principal Investigator
Funding: H LEE MOFFITT CANCER CTR & RES INST
via FL DEPT OF HLTH BIOMED RES PGM/J&E KING
Education
Cytopathology Fellowship
1975-1977
·
Jacksonville Health Education Programs (JHEP), Jacksonville, FL
Anatomic and Clinical Pathology Residency
1973-1975
·
Jacksonville Health Education Programs (JHEP), Jacksonville, FL
Doctor of Medicine
1967-1973
·
Shiraz University, Shiraz, Iran
Contact Details
Phones:
- Business:
- (904) 244-4387
Emails:
- Business:
- shahla.masood@jax.ufl.edu
Addresses:
- Business Mailing:
-
655 W 8TH ST, CLINICAL CTR 1ST FL
PATHOLOGY
JACKSONVILLE FL 32209 - Business Street:
-
655 W 8TH ST, CLINICAL CTR 1ST FL
DEPT OF PATHOLOGY
JACKSONVILLE FL 32209